75Y-24209-62779
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Moderna
-
2021-02-24
Registered in v-safe
- 2021-02-24
- 2021-02-26
-
2021-03-05
Dose 2 — Moderna
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-12
-
2021-03-19
Survey response — day 14, dose 2MedDRA: Hypersensitivity, Sinusitis — Feeling: FairFree text: Allergies/ sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-09-05
-
2022-03-06
Survey response — 12 months, dose 2MedDRA: Anxiety, COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID -19 AnxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-06 | Unsuccessful |
Free text
Release 5 — day 14, dose 2
Symptoms: Allergies/ sinus infection
Release 11 — 12 months, dose 2
Symptoms: COVID -19 Anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release